IP Library Granted Patent US 9,370,465
Granted Patent B2
US 9,370,465 · App. 14/047,083 · Granted Jun 21, 2016

Smart IV bag with optical IV drug identification tag

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,370,465
App. No.
14/047,083
Granted
Jun 21, 2016
Kind
B2
Abstract

This invention relates to a smart IV bag with a structurally integrated optical tag for IV drug identification and monitoring. The optical tag comprises a flow cell with a fluid channel in communication with the IV bag to sample a portion of the IV fluid onto an optical surface embedded in the flow cell. The optical surface causes a light beam to interact with the sampled IV fluid to produce a spectroscopic signal. The spectroscopic signal is then analyzed to obtain the content and concentration information of the IV fluid. Unlike traditional IV bag labels, the optical tag provides real-time, in-situ monitoring of IV fluid content and concentration, which greatly reduces the risk of mislabeling induced IV error.

Claims (20)

1. An intravenous (IV) fluid container with pre-filled IV fluid for IV therapy, said IV fluid container comprising a structurally integrated optical IV drug identification tag, said optical IV drug identification tag comprising:

a flow cell with a fluid channel in communication with said IV fluid container;

a one-directional breakable valve embedded in said fluid channel for sealing said fluid channel to said flow cell, said one-directional breakable valve is configured to allow a portion of the IV fluid to flow one-directionally from said IV fluid container into said flow cell when broke open; and

a surface enhanced Raman spectroscopy (SERS) active surface embedded in said flow cell, said SERS active surface is configured to receive said portion of the IV fluid and cause a light beam to interact with said portion of the IV fluid to produce a Raman scattering signal containing a content and concentration information of the IV fluid.

2. The IV fluid container of claim 1 , wherein said optical IV drug identification tag further comprising a transparent window for transmitting said light beam to said SERS active surface.

3. The IV fluid container of claim 1 , wherein said SERS active surface comprises a roughened metal surface with nanostructures.

4. The IV fluid container of claim 3 , wherein said nanostructures comprise surface gratings.

5. The IV fluid container of claim 1 , wherein said optical IV drug identification tag further comprising a filtration member embedded in said fluid channel, said filtration member is configured to remove a pre-determined content of the IV fluid.

6. A method for identifying and monitoring the content and concentration of intravenous (IV) fluid in an IV fluid container, the method comprising the steps of:

providing an optical IV drug identification tag structurally integrated with the IV fluid container, said optical IV drug identification tag comprising a flow cell with a fluid channel in communication with said IV fluid container, a one-directional breakable valve embedded in said fluid channel for sealing said fluid channel to said flow cell, said one-directional breakable valve is configured to allow a portion of the IV fluid to flow one-directionally from said IV fluid container into said flow cell when broke open, and a surface enhanced Raman spectroscopy (SERS) active surface embedded in said flow cell to receive said portion of the IV fluid;

causing a light beam to interact with said portion of the IV fluid in proximity to said SERS active surface to produce a Raman scattering signal; and

measuring said Raman scattering signal to obtain a content and concentration information of the IV fluid.

7. The method of claim 6 , wherein said optical IV drug identification tag further comprising a transparent window for transmitting said light beam to said SERS active surface.

8. The method of claim 6 , wherein said optical IV drug identification tag further comprising a filtration member embedded in said fluid channel, said filtration member is configured to remove a pre-determined content of the IV fluid.

9. An intravenous (IV) fluid container with pre-filled IV fluid for IV therapy, said IV fluid container comprising a structurally integrated optical IV drug identification tag, said optical IV drug identification tag comprising:

a flow cell with a fluid channel in communication with said IV fluid container;

a one-directional breakable valve embedded in said fluid channel for sealing said fluid channel to said flow cell, said one-directional breakable valve is configured to allow a portion of the IV fluid to flow one-directionally from said IV fluid container into said flow cell when broke open; and

a fluorescence active surface embedded in said flow cell, said fluorescence active surface is configured to receive said portion of the IV fluid and cause a light beam to interact with said portion of the IV fluid to produce a fluorescence signal containing a content and concentration information of the IV fluid.

10. The IV fluid container of claim 9 , wherein said fluorescence active surface comprises a dielectric grating deposited on a gold film.

11. The IV fluid container of claim 9 , wherein said optical IV drug identification tag further comprising a filtration member embedded in said fluid channel, said filtration member is configured to remove a pre-determined content of the IV fluid.

Assignments (2)
MERGER Recorded Oct 27, 2022
From: B&W TEK LLC
To: METROHM SPECTRO, INC.
Reel/Frame 061560/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2013
From: WANG, SEAN XIAOLU
To: BWT PROPERTY, INC.
Reel/Frame 031359/0359 →